This article is more than 5 years old. Information may no longer be current.

Imprimis reports 485% increase in revenue in 2015

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Imprimis Pharmaceuticals reported $9.7 million in revenue in 2015, a 485% increase from $1.6 million in 2014, according to a press release.

Revenue was reported at $3.5 million in the fourth quarter, a 500% increase from $0.5 million reported in the same quarter of 2014.

Net loss was reported at $15.9 million, or $1.66 per common share, in 2015 compared with $10.1 million, or $1.11 per common share, in 2014.

General and administrative expenses were reported at $12.5 million in 2015 compared with $8 million reported in 2014.